These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35600589)

  • 1. Investigating the Impact of the TUITEK
    Su PH; Malik S; Jheeta A; Lin YF; Su SH; Koledova E; Graham S
    Front Endocrinol (Lausanne); 2022; 13():897956. PubMed ID: 35600589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the TUITEK
    Assefi AR; Graham S; Crespo ML; Debicki M; Reston J; Gonzalez J; Jheeta A; Koledova E
    Front Endocrinol (Lausanne); 2023; 14():1129385. PubMed ID: 37091843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
    Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
    J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observed High Adherence to Recombinant Human Growth Hormone Treatment Using a Multi-Component Approach to Improve Adherence in Individuals with Growth Disorders.
    Morgan K; Van Dommelen P; Batista AR; Koledova E
    Stud Health Technol Inform; 2022 May; 294():817-818. PubMed ID: 35612215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 7. Adherence in children with growth hormone deficiency treated with r-hGH and the easypod™ device.
    Loche S; Salerno M; Garofalo P; Cardinale GM; Licenziati MR; Citro G; Caruso Nicoletti M; Cappa M; Longobardi S; Maghnie M; Perrone R
    J Endocrinol Invest; 2016 Dec; 39(12):1419-1424. PubMed ID: 27406716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of machine learning to identify patients at risk of sub-optimal adherence: study based on real-world data from 10,929 children using a connected auto-injector device.
    Spataru A; van Dommelen P; Arnaud L; Le Masne Q; Quarteroni S; Koledova E
    BMC Med Inform Decis Mak; 2022 Jul; 22(1):179. PubMed ID: 35794586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of nurse-led virtual reviews with growth hormone device-linked patient adherence information: a mixed methods feasibility study.
    Stokes H; Jones J; Worth C; Nicholson J; Fullwood C; Banerjee I
    Front Endocrinol (Lausanne); 2023; 14():1167854. PubMed ID: 37324260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.
    Bozzola M; Colle M; Halldin-Stenlid M; Larroque S; Zignani M;
    BMC Endocr Disord; 2011 Feb; 11():4. PubMed ID: 21294891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of treatment adherence with easypod™ in six Italian centers: a real-world experience.
    Cardinale GM; Pesce S; Ingletto D; Mariano M; Catucci A; Corciulo N; Fidotti E
    Minerva Endocrinol; 2019 Sep; 44(3):246-251. PubMed ID: 30482007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Felicio JS; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Sgarbi JA; Spinola-Castro AM; Cunha MPR; Bandeira F; Toffoletto O; Afiune J; Baradelli R; Rodrigues DG; Scharf M
    Growth Horm IGF Res; 2019; 48-49():29-35. PubMed ID: 31493626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Health in the Management of Pediatric Growth Hormone Therapy - 10 Years of Developments.
    Koledova E; Le Masne Q; Spataru A; Bagha M; Dixon D
    Stud Health Technol Inform; 2021 May; 281():926-930. PubMed ID: 34042809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of real-world data on growth hormone therapy adherence using a connected injection device.
    Koledova E; Tornincasa V; van Dommelen P
    BMC Med Inform Decis Mak; 2020 Jul; 20(1):176. PubMed ID: 32727461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency.
    Johannsson G; Nespithal K; Plöckinger U; Alam V; McLean M
    J Endocrinol Invest; 2018 Aug; 41(8):919-927. PubMed ID: 29488103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participatory Study to Explore Healthcare Professionals' Perceptions of a Connected Digital Solution for Adherence Monitoring of Recombinant Human Growth Hormone Treatment: Study Protocol and First Findings.
    Rivera-Romero O; Felicia Faienza M; Vergani E; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2023 May; 302():23-27. PubMed ID: 37203602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Data-Driven Intervention Framework for Improving Adherence to Growth Hormone Therapy Based on Clustering Analysis and Traffic Light Alerting Systems.
    Araújo M; van Dommelen P; Srivastava J; Koledova E
    Stud Health Technol Inform; 2021 Nov; 287():23-27. PubMed ID: 34795072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences for Injection Device Settings and the Association with Adherence to Growth Hormone Treatment in Patient with Growth Disorders.
    van Dommelen P; Rivera-Romero O; Arnaud L; Zucchiatti C; Koledova E
    Stud Health Technol Inform; 2024 Aug; 316():38-42. PubMed ID: 39176668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.